US FDA | The Business Standard
Skip to main content
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
The Business Standard

Tuesday
November 28, 2023

Sign In
Subscribe
  • Home
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Features
    • Book Review
    • Brands
    • Earth
    • Explorer
    • Food
    • Habitat
    • In Focus
    • Luxury
    • Mode
    • Panorama
    • Pursuit
    • Wheels
  • Epaper
    • GOVT. Ad
  • More
    • Subscribe
    • Videos
    • TBS Graduates
    • Thoughts
    • Splash
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • COVID-19
    • Long Read
    • Interviews
    • Offbeat
    • Tech
    • Magazine
  • বাংলা
TUESDAY, NOVEMBER 28, 2023

US FDA

Acme's muscle relaxant tablet 'Chlorzoxazone 500' gets US FDA approval
Stocks

Acme's muscle relaxant tablet 'Chlorzoxazone 500' gets US FDA approval

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly
World+Biz

US FDA says India-made eye drop linked to some infections, blindness and one death

A woman holds a small bottle labeled with a "Coronavirus Covid-19 Vaccine" sticker and a medical syringe in front of displayed Novavax logo in this illustration taken, October 30, 2020. Photo: Reuters
Coronavirus chronicle

US FDA authorizes Novavax Covid vaccine for adults

Photo: Collected
World+Biz

US approves first pill for treatment of alopecia

FILE PHOTO: An employee shows the Moderna coronavirus disease (Covid-19) vaccine at Northwell Health's Long Island Jewish Valley Stream hospital in New York, US, December 21, 2020. REUTERS/Eduardo Munoz
Coronavirus chronicle

US CDC backs full approval of Moderna's Covid-19 vaccine

Paxlovid, a Pfizer's coronavirus disease (Covid-19) pill, is seen manufactured in Ascoli, Italy, in this undated handout photo obtained by Reuters on November 16, 2021.  Photo :Reuters
Coronavirus chronicle

US FDA set to authorize Pfizer, Merck Covid-19 pills this week - Bloomberg News

FILE PHOTO: The headquarters of the US Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed
Coronavirus chronicle

US FDA lifts clinical hold on Inovio's Covid-19 vaccine trial

FILE PHOTO: A healthcare worker holds a vial of the Moderna COVID-19 vaccine at a pop-up vaccination site operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, U.S., January 29, 2021. REUTERS/Mike Segar/File Photo
Coronavirus chronicle

US FDA clears Moderna, J&J Covid-19 boosters, backs use of different vaccine for boost

Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
USA

US FDA gives marketing nod to an e-cigarette for the first time

Syringes filled with a dose of the Moderna Covid-19 vaccine sit on a table during an employee vaccination at the Sarasota Memorial Hospital in Sarasota, Florida, US, September 24, 2021. Photo :Reuters
Coronavirus chronicle

US FDA staff says Moderna did not meet all criteria for Covid-19 boosters

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

US FDA grants full approval to Pfizer-BioNTech Covid-19 vaccine

Syringe and vial are seen in front of displayed new Pfizer logo in this illustration taken, June 24, 2021. REUTERS/Dado Ruvic/Illustration
Coronavirus chronicle

Pfizer, BioNtech submit data to FDA for Covid-19 vaccine booster authorisation

FILE PHOTO: The headquarters of the US Food and Drug Administration (FDA) is shown in Silver Spring, Maryland, November 4, 2009. REUTERS/Jason Reed
Coronavirus chronicle

US FDA authorises Covid-19 vaccine boosters for the immunocompromised

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Privacy Policy
  • Comment Policy
Copyright © 2023
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net